Aspira Women’s Health Appoints John Ragard to Board

Aspira Women’s Health (AWH) just unveiled an update.

Aspira Women’s Health Inc. welcomes John Ragard to its Board of Directors, effective July 25, 2024. With 46 years of financial expertise, including roles as a venture capital investor and a portfolio manager with a track record of outperforming benchmarks, Ragard brings a wealth of knowledge to the team. His tenure will last until the 2025 annual meeting of stockholders, a move initiated by significant stockholder Jack W. Schuler under a 2013 agreement.

See more insights into AWH stock on TipRanks’ Stock Analysis page.